Member Info for mulledwine

According to IVD Technology's April 2012 edition, the characteristics of the Territory's 1.3 billion population are showing trends toward an increase in health problems such as heart disease, diabetes, and cancer common in developed countries with an aging population. With this in mind, the Territory's aggregate IVD market has been estimated to exceed $2 billion with an annual growth rate of approximately 25%. With heparin being a cost-effective, anti-coagulant mainstay, especially in cardiac surgery, rapid HIT screening tests are in-demand. PIFA's entrance into Asia's largest market has already been received positively by Novotek's customer base through their pre-launch market research programs and Novatek has committed to funding the costs of obtaining State Food & Drug Administration ("SFDA") approval which will enable the product to be sold throughout China. The Agreement spans an initial 9-year period with ABI retaining the right to terminate the agreement if Novatek fails to achieve progressive minimum annual sales. Subject to the minimum sales quantities outlined in the Agreement being achieved (of which there can be no guarantee) and it not being terminated by either party, the Agreement represents a potential $33.2m minimum contribution to ABI's revenues over the initial term. However, given the size of the market opportunity and with alternative rapid HIT screening tests largely absent from the Chinese clinical laboratory market place, the eventual contribution from the Agreement has the potential to be significantly higher.

Distribution Partnership Forged in China Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce the signing of a distribution agreement ("Agreement") with Novotek Therapeutics Inc ("Novotek"), a Beijing-based pharmaceutical and in vitro diagnostic business development corporation, for ABI's innovative Particle ImmunoFiltration Assay ("PIFA") products. The multi-year agreement assigns exclusive sales and marketing rights for the products to Novotek in Mainland China ("Territory"). ABI's PIFA technology platform facilitates the rapid detection of antibodies known to be the major determinant in the pathogenesis of heparin-induced thrombocytopenia ("HIT"), a life and limb-threatening potential complication of treatment with the blood thinner, heparin. In essence, a HIT patient develops an allergy to heparin transforming the drug into a clotting agent. Individuals undergoing cardiac and major orthopaedic surgeries are especially vulnerable. The quick and accurate assessment of the patients HIT-antibody status, provided by the Company's PIFA Heparin/PF4 and the newly launched PIFA PLUSS PF4 rapid assays, is a key factor in a physician's ability to rule-out or diagnose the condition.

http://www.investegate.co.uk/akers-biosciences-(akr)/rns/distribution-partnership-forged-in-china/201211260700069381R/

Peter Lawrence, Chairman of ECO, commented “This latest authorisation in Russia is another extremely encouraging and positive step in the development of Aivlosin® as a truly global brand and underlines ECO’s commitment to becoming a major force in the international market for veterinary pharmaceutical products.”

CO RECEIVES FIRST MARKETING AUTHORISATION FOR AIVLOSIN® IN RUSSIA ECO is pleased to report that the Ministry of Agriculture of the Russian Federation has granted ECO a marketing authorisation for Aivlosin® 42.5 mg/g premix for swine. Russia is the seventh largest pork producing country and it has seen a 50 per cent growth in pork production between 2006 and 2011 driven by both domestic demand and import substitution, with growing adoption of large scale, intensive production techniques. This initial and very important Russian authorisation comes just four months after the US Food and Drug Administration granted ECO its first marketing authorisation in the United States for Aivlosin® 625 mg/g water soluble granules for swine. Aivlosin®, ECO’s patented macrolide antibiotic, is used for the treatment of respiratory and enteric (gut) diseases in pigs and poultry.

http://www.investegate.co.uk/eco-animal-health-(eah)/bus/regulatory-approval/20121126070000Z3174/

Bullabulling Gold Managing Director Brett Lambert said: "This transaction represents a sensible step in our progress towards development through removing a constraint to mining and providing greater flexibility in how we manage the site. Ownership of this tenement will improve already strong growth prospects with potential short and long term benefits, particularly the ability to pursue extensions to higher grade mineralisation at Edwards."

Bullabulling Gold Limited ("Bullabulling Gold" or the "Company") advises that it has agreed to acquire mining lease M15/552 from Resolute Mining Limited in exchange for 13.5 million ordinary shares ("Acquisition Shares") in Bullabulling Gold. M15/552 is situated immediately west of the Bullabulling gold deposit and is surrounded on three sides by Bullabulling Gold's existing tenements. While the main body of mineralisation being targeted for development by Bullabulling Gold is located within the Company's existing tenure, work carried out during the pre-feasibility study indicates that the optimal open pit crest would encroach on M15/552 such that a portion of the targeted resource could not be extracted without access to this tenement. Control of M15/552 also provides Bullabulling Gold with additional growth opportunities. The Bullabulling gold deposit dips west towards M15/552 and remains open down dip, with drilling to date already intersecting mineralisation beyond the limit of the current resource. Furthermore, the southern extension of the Bullabulling trend, which has not been extensively explored, is closer to M15/552 and mineralisation is known to cross the lease boundary at a relatively shallow depth, particularly at the Edwards Prospect where the resource grade is higher than the Bullabulling average. Bullabulling Gold's future exploration of the southern trend, including potential down dip extensions to the Edwards Prospect, will no longer be constrained by the tenement boundary. Bullabulling Gold will now also have greater flexibility in placing waste rock dumps, haulage roads and other infrastructure, which may lead to improved project economics, particularly where haulage distances can be reduced. The acquisition remains conditional on Bullabulling Gold completing due diligence within ten business days. Upon completion of the transaction, Resolute will hold 4.5% of Bullabulling Gold's equity as enlarged by the Acquisition Shares. Following completion the company will make application for the Acquisition Shares to be admitted to the ASX and AIM and the Company will have a total of 302,533,871 Ordinary Shares on issue. Bullabulling Gold will assume Resolute's obligation to pay a royalty to Pacific-Nevada Mining Pty Ltd equivalent to one percent of the value of gold produced and sold directly from M15/552. This obligation will not apply to additional gold produced from the Company's other tenements as a result of being able to access M15/552.

Bullabulling Gold Limited 26 November 2012 AIM Code: BGL, ASX Code: BAB Additional Mining Lease Acquired at Bullabulling · Rationalises tenement ownership and improves access while opening up new growth opportunities · Removes a potential restriction to optimal open pit development · Provides greater access to down dip extensions of the Bullabulling deposit · Ensures the Company can fully exploit the southern extension of the Bullabulling Trend including higher grade mineralisation at the Edwards Prospect · Provides greater flexibility for the placement of waste dumps and infrastructure

http://www.investegate.co.uk/bullabulling-gold-(bgl)/rns/additional-mining-lease-acquired/201211260700059153R/

Not too bad at all.

Outlook The business is diverse in terms of the geographies and sectors within which it operates. Although margin pressure continues to depress the trading performance in some regions, including China and Europe, we are nevertheless seeing an encouraging improvement in the financial performance of the Middle East. We are focused on operating within our banking arrangements with further benefits from PFI disposals. The first half performance, the forward order book and our continuing PFI/PPP asset disposal programme point to a stabilisation of the Group's fortunes and improving medium term prospects.

Results Group revenue for the period was £37.7m (2012 H1: £36.1m). Pre exceptional operating profit was £2.5m (2012 H1: £1.0m) and operating profit margin was 6.6% (2012 H1: 2.8%). Pre exceptional profit before tax was £2.1m (2012 H1: £0.9m). Profit before tax was £1.6m (2012 H1: loss of £0.2m) and basic earnings per share were 1.8p (2012 H1: loss of 0.5p). At the period end the Group had net borrowings of £9.5m (2012 H1: £10.8m). Exceptional administrative expenses of £0.3m (2012 H1: £0.9m and 2012 FY: £1.3m) comprised restructuring initiatives to reduce the ongoing cost base. Amortisation of acquired intangibles amounted to £0.2m (2012 H1: £0.2m and 2012 FY: £0.5m). Exchange rate movements in the Group's major trading currencies had a minimal impact on both revenue and results.

Chairman Michael Henderson said: "The improved trading performance was in-line with management's expectations. The disposal of our investments in the Plymouth LIFT and Inverclyde Schools PFI projects generated £1.2m of the profit reported for the period. This programme of disposals is designed to release funds to reduce net debt and to reinvest in our core business operations. "In Europe we continue to benefit from the restructuring actions completed last year, whilst our investments in the energy and infrastructure sectors have resulted in a number of major commissions. "We have refocused our Middle East business and have returned to profitability. "The Group's main target growth market remains Asia Pacific although we are seeing a slowdown in China due to the slowing economy. Diversifying our service offering and sector expertise and cross-selling opportunities throughout the whole of the region is, however, starting to provide benefits. In Australia we are re-aligning our business to the more vibrant private sector, which includes direct investors from China. "The Group's order book currently stands at £92m and shows a healthy split between Europe (40%), Asia Pacific (54%) and MEAI (6%). The benefits of the Group's global footprint are also evidenced by the order book's balance, with a pick-up in bidding activity across all regions. "Although net debt increased from the year end due to an increase in receivables, particularly in China, we have kept well within our banking covenants. "The business is diverse in terms of the geographies and sectors within which it operates. Although margin pressure continues to depress the trading performance in some regions, including China and Europe, we are nevertheless seeing an encouraging improvement in the financial performance of the Middle East. We are focused on operating within our banking arrangements with further benefits from PFI disposals. The first half performance, successful entry into new sectors, forward order book and our continuing PFI/PPP asset disposal programme point to a stabilisation of the Group's fortunes and improving medium term prospects."

Operational highlights · Diversified order book continues to grow and now stands at £92m (31 March 2012: £90m), 60% of which represents orders from outside Europe; · Full benefit now being realised from last year's restructuring, resulting in £2m of annualised cost savings; · Solid operational performance in Europe, with a number of significant commissions in energy and infrastructure sectors; · Divestment of PFI assets proceeding according to plan; · Middle East business returns to profitability; · Slowdown in Chinese economy and Australian public sector spending reflected in Asia Pacific operating performance.

http://www.investegate.co.uk/sweett-group-(csg)/rns/interim-results/201211230700138436R/

Lyn Duncan, co-founder of @UK commented, "The visit to Australia was worthwhile, building upon all of the pre-sales work undertaken by the team. The Australian market is technically literate and understands the differentiated nature of our offering. The fusion of buyer driven eprocurement and genuine supplier ecommerce, underpinned by an active and engaged banking sector has the potential to become pervasive. Importantly, there is also a lack of legacy systems in place which traditionally slow down change and the uptake of new technology. We are therefore confident that these activities will deliver significant opportunities."

Update on @Australia @UK PLC (AIM:ATUK.L), the cloud ecommerce marketplace, is pleased to announce that following the launch of @Australia in September this year, the @UK sales team conducted a two month campaign to select prospects which culminated in a successful three week sales visit in October and November by @UK senior management. The visit saw meetings with four of the Australian Regional Governments, covering areas as diverse as health, education, research, local government and economic development. The visit confirmed that there is a real appetite for the Company's solutions, ranging from spend analytics through to the ecommerce marketplace with secure embedded payment. To support and accelerate the roll out of this innovative solution the Company has engaged with a number of Australia's major banks, demonstrating the solution to their sales and product teams. As a consequence of this activity, the Company has run a number of spend analytics test files and is actively engaged in providing proposals to prospects. It is the Company's intention to establish a small team in Australia during 2013 and the Board believes revenues from Australia have the potential to be greater than UK revenues.

http://www.investegate.co.uk/uk-plc-(atuk)/rns/update-on-australia/201211230700228483R/

CONT We have successfully produced a number of events globally for major household names and also for some leading professional service clients. These events were held in a variety of cities from Cannes to Kuala Lumpur, and our extensive experience in producing innovative live events has seen many clients returning to us time and again for their conference and events needs. In line with our continued strategy to provide a cutting edge service to clients, we took the decision to dispose of our DVD department, due primarily to the declining relevance of DVDs in the current market and the loss of our BBC contract. We have acted quickly to remove the overhead and we feel that the impact will be minimal on the year ahead. The results for the year show a loss before taxation of £82,841 (2011: £90,336). Revenue for the year was £2,899,602 (2011: £2,147,844). The loss before taxation was due in part to the acquisition of viral agency ST16 which has not resulted in the volume of business anticipated. The Board is taking action to resolve the issue and will update the market at the appropriate time. We remain cash positive with reserves of £756,642 (2011: £528,415). Over the past year we increased our revenues whilst still ensuring that our corporate communications and events proposition remains modern and adaptable to changes and trends within the sector. I see this as a strong success for Aeorema. Looking ahead we look forward to building our client roster across our suite of products and services. Finally I would like to take this opportunity to thank shareholders for their support and would also like to place particular thanks to our dedicated and talented creative teams for their hard work over the period. M Hale Chairman 19 November 2012